From concept to practice: real-world safety of JAK inhibitors in rheumatoid arthritis treatment
Year: 2026
Type: article
Abstract: Janus kinase inhibitors have emerged as highly effective therapies, gaining a prominent role in rheumatoid arthritis treatment. However, by inhibiting multiple cytokine effector pathways, these agents have also raised concerns regarding their safety profile. This article aims to provide an updated overview of the main safety aspects of JAK inhibitors, with a particular focus on their use in RA.
Source: Frontiers in Medicine
Author: Karina R. Bonfiglioli
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7128781623
